Cavendish Laboratory, University of Cambridge, JJ Thomson Avenue, Cambridge CB3 0HE, United Kingdom; Living Systems Institute, University of Exeter, Stocker Road, Exeter EX4 4QD, United Kingdom.
Life Sciences, University of Warwick, Coventry CV4 7AL, United Kingdom.
J Mol Biol. 2019 Aug 23;431(18):3531-3546. doi: 10.1016/j.jmb.2019.03.031. Epub 2019 Apr 5.
The double-membrane cell envelope of Gram-negative bacteria is a sophisticated barrier that facilitates the uptake of nutrients and protects the organism from toxic compounds. An antibiotic molecule must find its way through the negatively charged lipopolysaccharide layer on the outer surface, pass through either a porin or the hydrophobic layer of the outer membrane, then traverse the hydrophilic peptidoglycan layer only to find another hydrophobic lipid bilayer before it finally enters the cytoplasm, where it typically finds its target. This complex uptake pathway with very different physico-chemical properties is one reason that Gram-negative are intrinsically protected against multiple classes of antibiotic-like molecules, and is likely the main reason that in vitro target-based screening programs have failed to deliver novel antibiotics for these organisms. Due to the lack of general methods available for quantifying the flux of drugs into the cell, little is known about permeation rates, transport pathways and accumulation at the target sites for particular molecules. Here we summarize the current tools available for measuring antibiotic uptake across the different compartments of Gram-negative bacteria.
革兰氏阴性菌的双层细胞膜是一个复杂的屏障,它有助于吸收营养物质,并保护生物体免受有毒化合物的侵害。抗生素分子必须穿过外表面带负电荷的脂多糖层,通过孔蛋白或外膜的疏水区,然后穿过亲水区的肽聚糖层,才能找到另一个疏水性脂质双层,最后进入细胞质,在那里它通常会找到它的靶标。这种具有非常不同理化性质的复杂摄取途径是革兰氏阴性菌对多种类抗生素样分子具有内在保护作用的原因之一,这也是体外基于靶标的筛选计划未能为这些生物体提供新抗生素的主要原因。由于缺乏通用的方法来定量测定药物进入细胞的通量,因此对于特定分子在不同部位的渗透速率、转运途径和积累情况知之甚少。在这里,我们总结了目前可用于测量革兰氏阴性菌不同隔室中抗生素摄取的工具。